Ai-biopharma is proud to be one of 37 partners in the CARE consortium – Europe’s largest initiative with a grant totaling € 77.7 million to accelerate therapy development for COVID19 and future coronavirus threats.
Ai-biopharma is proud to be one of 37 partners in the CARE consortium – Europe’s largest initiative with a grant totaling € 77.7 million to accelerate therapy development for COVID19 and future coronavirus threats.
